A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children

Shigella sonnei live vaccine candidate, WRSS1, which was previously evaluated in US, Israeli and Thai volunteers, was administered orally to Bangladeshi adults and children to assess its safety, clinical tolerability and immunogenicity. In a randomized, placebo-controlled, dose-escalation, age-desce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Raqib, Rubhana, Sarker, Protim, Zaman, K., Alam, Nur Haque, Wierzba, Thomas F., Maier, Nicole, Talukder, Kaisar, Baqui, Abdullah Hel, Suvarnapunya, Akamol E., Qadri, Firdausi, Walker, Richard I., Fix, Alan, Venkatesan, Malabi M.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663145/
https://ncbi.nlm.nih.gov/pubmed/30794051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1575165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados